Literature DB >> 24055471

ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin.

Adam V Jones1, Daniel W Lambert, Paul M Speight, Simon A Whawell.   

Abstract

A disintegrin and metalloprotease (ADAM) proteins are upregulated in cancer and can interact with integrin receptors. We investigated whether such interactions may have functional significance in oral squamous cell carcinoma (OSCC). ADAM 10 expression was increased in OSCC tissue and cell lines compared to normal oral mucosa. Silencing of ADAM 10 reduced migration and invasion specifically in OSCC cells over-expressing αvβ6 integrin. This may result from ADAM 10-induced up-regulation of MMPs. We conclude ADAM 10 may influence OSCC invasion by functionally interacting with αvβ6 integrin which we have previously shown is over expressed in OSCC.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADAM 10; Oral squamous cell carcinoma; αvβ6 integrin

Mesh:

Substances:

Year:  2013        PMID: 24055471     DOI: 10.1016/j.febslet.2013.09.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Notch signaling in oral pre-cancer and oral cancer.

Authors:  Kumud Nigam; Ratnesh Kumar Srivastav
Journal:  Med Oncol       Date:  2021-10-11       Impact factor: 3.064

2.  Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.

Authors:  José Sergio Zepeda-Nuño; Celia Guerrero-Velázquez; Susana Del Toro-Arreola; Natali Vega-Magaña; Julián Ángeles-Sánchez; Jesse Haramati; Ana L Pereira-Suárez; Miriam R Bueno-Topete
Journal:  Pathol Oncol Res       Date:  2016-09-14       Impact factor: 3.201

3.  Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma Progression.

Authors:  Célimène Galiger; Stefanie Löffek; Marc P Stemmler; Jasmin K Kroeger; Venugopal R Mittapalli; Lisa Fauth; Philipp R Esser; Johannes S Kern; Frank Meiss; Silke Laßmann; Leena Bruckner-Tuderman; Claus-Werner Franzke
Journal:  Mol Ther       Date:  2017-09-27       Impact factor: 11.454

4.  Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113.

Authors:  Yuan Shao; Xiao-Ying Sha; Yan-Xia Bai; Fang Quan; Sheng-Li Wu
Journal:  Mol Med Rep       Date:  2014-10-21       Impact factor: 2.952

5.  Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.

Authors:  Yu-Chao Chang; Chia-Ing Jan; Chih-Yu Peng; Yu-Chi Lai; Fang-Wei Hu; Cheng-Chia Yu
Journal:  Oncotarget       Date:  2015-09-15

Review 6.  Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.

Authors:  D Dreymueller; K Theodorou; M Donners; A Ludwig
Journal:  Mediators Inflamm       Date:  2017-02-05       Impact factor: 4.711

7.  Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results.

Authors:  Katarzyna Walkiewicz; Joanna Strzelczyk; Dariusz Waniczek; Krzysztof Biernacki; Małgorzata Muc-Wierzgoń; Angelika Copija; Ewa Nowakowska-Zajdel
Journal:  Dis Markers       Date:  2019-09-02       Impact factor: 3.434

Review 8.  The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?

Authors:  Pierre Dourlen; Devrim Kilinc; Nicolas Malmanche; Julien Chapuis; Jean-Charles Lambert
Journal:  Acta Neuropathol       Date:  2019-04-13       Impact factor: 17.088

9.  A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic.

Authors:  Wei Liu; Jie Li; Ping Zhang; Qiaoyun Hou; Shi Feng; Lisheng Liu; Dawei Cui; Hubing Shi; Yan Fu; Yongzhang Luo
Journal:  Cancer Sci       Date:  2019-08-09       Impact factor: 6.716

10.  Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics.

Authors:  Jr-Shiang Shiu; Ming-Ju Hsieh; Hui-Ling Chiou; Hsiang-Ling Wang; Chao-Bin Yeh; Shun-Fa Yang; Ying-Erh Chou
Journal:  Int J Med Sci       Date:  2018-08-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.